Disclosure
Dr Mark Kaddumukasa reports grants from National Institute of Neurological Disorders and Stroke and Fogarty International Center of the National Institute of Health under award number R01NS118544 and D43NS118560 outside the submitted work. Dr Martha Sajatovic reports grants from Otsuka, International Society for Bipolar Disorders (ISBD), National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Patient-Centered Outcomes Research Institute (PCORI), personal fees from Alkermes, Otsuka, Sunovion, Janssen, Lundbeck, Teva, Clinical Education Alliance, Health Analytics, Publication Royalties from Springer Press, Johns Hopkins University Press, Oxford Press, UpToDate, compensation for preparation of/participation in Continuing Medical Education (CME) activities from American Physician’s Institute (CMEtoGo), Psychopharmacology Institute, American Epilepsy Society, American Society of Clinical Psychopharmacology, American Academy of Child and Adolescent Psychiatry, Neurocrine, outside the submitted work. The authors report no other conflicts of interest in this communication.